These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30737360)

  • 21. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
    Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
    J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
    Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation.
    Hsu JY; Chang KY; Chen SH; Lee CT; Chang ST; Cheng HC; Chang WC; Chen BK
    Oncotarget; 2015 Jan; 6(3):1723-39. PubMed ID: 25595899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).
    Mutallip M; Nohata N; Hanazawa T; Kikkawa N; Horiguchi S; Fujimura L; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Mol Med; 2011 Mar; 27(3):345-52. PubMed ID: 21181092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
    Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
    Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
    Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.
    Lu WC; Liu CJ; Tu HF; Chung YT; Yang CC; Kao SY; Chang KW; Lin SC
    Oncotarget; 2016 Aug; 7(35):57254-57267. PubMed ID: 27528032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
    Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
    Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
    Xue K; Li J; Nan S; Zhao X; Xu C
    Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
    Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
    Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas.
    Harris T; Jimenez L; Kawachi N; Fan JB; Chen J; Belbin T; Ramnauth A; Loudig O; Keller CE; Smith R; Prystowsky MB; Schlecht NF; Segall JE; Childs G
    Am J Pathol; 2012 Mar; 180(3):917-928. PubMed ID: 22234174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling.
    Daly C; Castanaro C; Zhang W; Zhang Q; Wei Y; Ni M; Young TM; Zhang L; Burova E; Thurston G
    Oncogene; 2017 Jan; 36(4):471-481. PubMed ID: 27345413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors.
    O-charoenrat P; Rhys-Evans PH; Archer DJ; Eccles SA
    Oral Oncol; 2002 Jan; 38(1):73-80. PubMed ID: 11755824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
    Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
    Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.